Picture of bluebird bio logo

BLUE — bluebird bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid

March 28 (Reuters) - bluebird bio Inc BLUE.O:

BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID

RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE

AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES

BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS

NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL

Source text: ID:nBwb6Pg2da

Further company coverage: BLUE.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on bluebird bio

See all news